Novel inflammatory biomarkers in the prognosis of COVID-19.

ABSTRACT:

Background

The central role of inflammatory progression in the development of Coronavirus disease 2019 (COVID-19), especially in severe cases, is indisputable. However, the role of some novel inflammatory biomarkers in the prognosis of COVID-19 remains controversial.

Objective

To assess the effect of some novel inflammatory biomarkers in the occurrence and prognosis of COVID-19.

Methods

We systematically retrieved the studies related to COVID-19 and the inflammatory biomarkers of interest. The data of each biomarker in different groups were extracted, then were categorized and pooled. The standardized mean difference was chosen as an effect size measure to compare the difference between groups.

Results

A total of 90 studies with 12,059 participants were include

SUBMITTER: Zhan K 

PROVIDER: S-EPMC10515606 | biostudies-literature | 2023 Jan-Dec

REPOSITORIES: biostudies-literature